432 results on '"Gómez-Puerta, José A"'
Search Results
2. Autoimmune and Rheumatic Diseases and Sexuality
3. Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis
4. Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas y sintéticas dirigidas en la artritis reumatoide
5. OMERACT systemic lupus erythematosus domain survey
6. Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
7. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression
8. From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies
9. Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report
10. Clinical trials: General concepts and interpretation
11. Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus
12. Importancia de los títulos de anticuerpos antifosfolípidos no criterio entre pacientes con síndrome antifosfolípido primario y pacientes con lupus eritematoso sistémico
13. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
14. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
15. Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas
16. Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines
17. Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients.
18. Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.
19. Teachers' Beliefs about Diversity: An Analysis from a Personal and Professional Perspective
20. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study
21. Interstitial lung disease and rheumatoid arthritis
22. Diagnosis and treatment of articular manifestations of systemic lupus erythematosus
23. Comparable long-term outcomes between DAS28-ESR remission criteria and ACR/EULAR definitions in patients with established rheumatoid arthritis
24. Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis
25. Poliautoinmunidad en síndrome de Sjögren
26. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis
27. Transferrina y ceruloplasmina en orina de pacientes con lupus eritematoso sistémico. ¿Son útiles para diferenciar pacientes con nefritis lúpica?
28. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients
29. Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice
30. Real-world data on anifrolumab, the new kid on the block in lupus
31. O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort
32. Controversies in Systemic Lupus Erythematosus: Are We Treating Our Patients Adequately?
33. Expanding diagnostic approach in patients with osteonecrosis
34. Controversies in Systemic Lupus Erythematosus: Are We Treating Our Patients Adequately?
35. Coexistence of antiphospholipid syndrome and cryoglobulinemia in a patient with rheumatoid arthritis
36. 19 Management of musculoskeletal involvement in SLE
37. LP-149 Latin-American systemic lupus erythematosus clusters
38. LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort
39. LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort
40. Systemic Lupus Erythematosus and Antiphospholipid Syndrome
41. IgG4-related Disease: A Concise Review of the Current Literature
42. Enfermedad relacionada con IgG4: revisión concisa de la literatura
43. Role of TWEAK/Fn14 signalling pathway in lupus nephritis and other clinical settings
44. Papel de la vía de señalización del TWEAK/Fn14 en la nefritis lúpica y otros escenarios clínicos
45. Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
46. OA06 Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions
47. Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression
48. The Spectrum of Rheumatic Diseases
49. Complete disappearance of pulmonary rheumatoid nodules after long term rituximab treatment: case report
50. Another step in lupus nephritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.